A detailed history of Pathstone Family Office, LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 13,526 shares of OSUR stock, worth $53,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,526
Holding current value
$53,157
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$4.4 - $6.91 $59,514 - $93,464
13,526 New
13,526 $80,000
Q4 2022

Oct 23, 2023

BUY
$4.26 - $5.29 $178,689 - $221,894
41,946 Added 144.91%
70,893 $341,000
Q4 2022

Feb 13, 2023

BUY
$4.26 - $5.29 $19,327 - $24,000
4,537 Added 6.84%
70,893 $341,000
Q3 2022

Oct 23, 2023

BUY
$2.72 - $4.61 $78,735 - $133,445
28,947 New
28,947 $105,000
Q3 2022

Nov 14, 2022

BUY
$2.72 - $4.61 $85,225 - $144,445
31,333 Added 89.46%
66,356 $251,000
Q2 2022

Aug 15, 2022

BUY
$2.71 - $7.12 $94,912 - $249,363
35,023 New
35,023 $94,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $285M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.